Why the study?
Arrhythmic events increased during the COVID-19 outbreak, but the frequency of severe ventricular arrhythmias and ICD device therapy in COVID-19 patients with an ICD had not been sufficiently reported.
Does COVID-19 infection increase the frequency of severe ventricular arrhythmias and ICD therapies in patients with an ICD?
Observational (n=33)
No
Does COVID-19 infection increase the frequency of severe ventricular arrhythmias and ICD therapies in patients with an ICD?
Answers are grounded in this paper and cite their sources.
COVID-19 infection significantly increases the burden of life-threatening ventricular arrhythmias and appropriate ICD therapies in patients with pre-existing ICDs.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Aktaş et al. (2022) conducted an observational in COVID-19 patients with Implantable Cardioverter-Defibrillator (ICD) (n=33). COVID-19 infection vs. Pre-COVID-19 period (90 days prior) was evaluated on Development of ventricular tachycardia (VT) and ventricular fibrillation (VF) (RR 2.86, 95% CI 1.57-5.19, p=<0.0006).
Synapse has enriched 10 related papers. Consider them for comparative context: